Home Tags PureTech Health

Tag: PureTech Health

United States Clinical-Stage Neuropsychiatric Disorders Company Seaport Therapeutics Nasdaq IPO Share...

0
United States Clinical-Stage Neuropsychiatric Disorders Company Seaport Therapeutics Nasdaq IPO Share Price Increased +10.2% on Day 1 Trading (1/5/26: IPO Price: $18, Closing $19.84)...

United States Clinical-Stage Neuropsychiatric Disorders Company Seaport Therapeutics Nasdaq IPO to...

0
United States Clinical-Stage Neuropsychiatric Disorders Company Seaport Therapeutics Nasdaq IPO to Raise $212 Million at $912 Million Valuation, Launched in 2024 by PureTech Health...